Insights into the expanding phenotypic spectrum of inherited disorders of biogenic amines
-
Published:2021-09-20
Issue:1
Volume:12
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Kuseyri Hübschmann OyaORCID, Horvath Gabriella, Cortès-Saladelafont Elisenda, Yıldız YılmazORCID, Mastrangelo Mario, Pons Roser, Friedman Jennifer, Mercimek-Andrews SaadetORCID, Wong Suet-Na, Pearson Toni S.ORCID, Zafeiriou Dimitrios I., Kulhánek Jan, Kurian Manju A., López-Laso Eduardo, Oppebøen Mari, Kılavuz Sebile, Wassenberg Tessa, Goez Helly, Scholl-Bürgi Sabine, Porta Francesco, Honzík Tomáš, Santer René, Burlina Alberto, Sivri H. SerapORCID, Leuzzi Vincenzo, Hoffmann Georg F., Jeltsch Kathrin, Hübschmann Daniel, Garbade Sven F.ORCID, Assmann Birgit, Fung Cheuk-Wing, Guder Philipp, Hong Stacey Tay Kiat, Karall Daniela, Kato Mitsuhiro, Kavecan Ivana, Koht Jeanette Aimee, Kuster Alice, Lücke Thomas, Manti Filippo, Mir Pablo, Mühlhausen Chris, Önenli Mungan Halise Neslihan, Palacios Natalia Alexandra Julia, Ramos Joaquín Alejandro Fernández, Steel Dora, Stevanović Galina, Sykut-Cegielska Jolanta, Verbeek Marcel M., García-Cazorla Angeles, Opladen ThomasORCID,
Abstract
AbstractInherited disorders of neurotransmitter metabolism are rare neurodevelopmental diseases presenting with movement disorders and global developmental delay. This study presents the results of the first standardized deep phenotyping approach and describes the clinical and biochemical presentation at disease onset as well as diagnostic approaches of 275 patients from the registry of the International Working Group on Neurotransmitter related Disorders. The results reveal an increased rate of prematurity, a high risk for being small for gestational age and for congenital microcephaly in some disorders. Age at diagnosis and the diagnostic delay are influenced by the diagnostic methods applied and by disease-specific symptoms. The timepoint of investigation was also a significant factor: delay to diagnosis has decreased in recent years, possibly due to novel diagnostic approaches or raised awareness. Although each disorder has a specific biochemical pattern, we observed confounding exceptions to the rule. The data provide comprehensive insights into the phenotypic spectrum of neurotransmitter disorders.
Funder
Dietmar Hopp Stiftung Rosetrees Trust
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference62 articles.
1. Nestler, E. J., Hyman, S. E., Holtzman, D. M. & Malenka, R. C. Molecular neuropharmacology: a foundation for clinical neuroscience (2015). 2. Ng, J., Papandreou, A., Heales, S. J. & Kurian, M. A. Monoamine neurotransmitter disorders–clinical advances and future perspectives. Nat. Rev. Neurol. 11, 567–584 (2015). 3. Jung-Klawitter, S. & Kuseyri Hubschmann, O. Analysis of catecholamines and pterins in inborn errors of monoamine neurotransmitter metabolism-from past to future. Cells 8, 867 (2019). 4. Jaggi, L. et al. Outcome and long-term follow-up of 36 patients with tetrahydrobiopterin deficiency. Mol. Genet. Metab. 93, 295–305 (2008). 5. Opladen, T., Hoffmann, G. F. & Blau, N. An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia. J. Inherit. Metab. Dis. 35, 963–973 (2012).
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|